Company intelligence / Profile preview

Advalytix

Brunnthal, Bavaria, Germany

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Advalytix was a German biotechnology company specializing in microfluidic solutions for life science research and molecular diagnostics. Founded in 2000 as a spin-off from the University of Munich, the company developed a proprietary platform based on Surface Acoustic Wave (SAW) technology to manipulate nanoliter liquid volumes on a chip. Its flagship product, the AmpliGrid, enabled high-throughput single-cell PCR and genomic analysis on a microscope slide format. The company's innovations significantly advanced the field of miniaturized assays and low-volume liquid handling. Advalytix was acquired by Olympus in 2005 to serve as a core component of its molecular biology business unit.

Modalities: Device
Industry: Molecular Diagnostics

Partnerships

Olympus

Beyond the preview

Go deeper on Advalytix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advalytix.

Explore the full profile